Immusoft

Immusoft is a Washington-based clinical-stage biotechnology company that develops novel therapies for the treatment of genetic diseases.

Business Model:

Revenue: $4M

Employees: 11-50

Detailed Immusoft Information

Geographic Data

Immusoft headquarters map

Address: 454 N 34th Street

City: Seattle

State: WA

Zip: 98103

Country: US

Financial Info

Stage:

grant

Raised Last:

$4M

Raised Total:

$41M

Metrics

8,816,021Website Global Rank

258Website Monthly Traffic

Twitter Followers

Description

Immusoft is a Washington-based clinical-stage biotechnology company that develops novel therapies for the treatment of genetic diseases.

Contact Phone:
+12063970028

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2021 Grant 1 $4M California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
9/2018 Grant 1 $3.5M National Institute of General Medical Science
National Institute of General Medical Science
9/2020 Equity $4.1M Breakout Ventures
Oisin Biotechnologies
Zentalis Pharmaceuticals
4/2012 Grant 2 $350k The Thiel Foundation
Breakout Labs
1/2019 Series B $0 Breakout Ventures
Alexandria Venture Investments
RBV Capital
GRIDS Capital
Mesa Verde Venture Partners
Bios Partners
DEFTA Partners
Breakout Ventures
Alexandria Venture Investments
RBV Capital
GRIDS Capital
Mesa Verde Venture Partners
Bios Partners
DEFTA Partners
1/2023 Grant $8M California Institute For Regenerative Medicine
9/2020 Venture Round $0 Breakout Ventures
Ikarian Capital
Mesa Verde Venture Partners
Breakout Ventures
Ikarian Capital
Mesa Verde Venture Partners
8/2015 Debt Financing $0 Westcott LLC
Westcott LLC
1/2023 Grant 1 $8M California Institute for Regenerative Medicine
California Institute For Regenerative Medicine
California Institute For Regenerative Medicine
California Institute for Regenerative Medicine
California Institute For Regenerative Medicine
California Institute For Regenerative Medicine
1/2019 Series B $16.4M Breakout Ventures
RBV Capital
DEFTA Partners
Mesa Verde Venture Partners
9/2009 Angel Round 1 - Boston Harbor Angels
Boston Harbor Angels
1/2018 Series B 6 $3M 600 Mile Challenge Fund
Tim Draper
Technium Partners
Peter Thiel
Invariantes Fund
EQx Fund
600 Mile Challenge Fund
9/2020 Grant 1 $467k National Institutes of Health
National Institutes of Health
11/2016 Series A 4 $2.7M FF Science
Technium Partners
Propel(X)
Breakout Ventures
FF Science
Technium Partners
8/2014 Series A 2 $2.4M Founders Fund
Westcott LLC
Founders Fund
9/2020 Venture Round 3 $4.5M Breakout Ventures
Ikarian Capital
Mesa Verde Venture Partners
Breakout Ventures
Ikarian Capital
Mesa Verde Venture Partners
1/2019 Series B 7 $20M Breakout Ventures
Alexandria Venture Investments
RBV Capital
GRIDS Capital
Mesa Verde Venture Partners
Breakout Ventures
Alexandria Venture Investments
RBV Capital
GRIDS Capital
Mesa Verde Venture Partners
8/2015 Debt Financing 1 $375k
Announced Date Name Price
3/2016 Discovery Genomics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research